Eton Pharmaceuticals, Inc. ETON Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $25.94M+73.7% | $14.94M-30.2% | $21.39M+31.2% | $16.31M+13.2% | ||
| $55.69M+178% | $20.07M+56.0% | $12.86M+158% | $4.98M-22.9% | ||
| $69.69M+223% | $21.56M+570% | $3.22M+54.6% | $2.08M-40.2% | ||
| $7.46M+35.9% | $5.49M+386% | $1.13M-12.5% | $1.29M-59.4% | ||
| $60.58M+47.7% | $41.02M+52.8% | $26.84M+34.2% | $20M-15.3% | ||
| $326K+859% | $34K-41.4% | $58K-19.4% | $72K-37.4% | ||
| $310K+77.1% | $175K+90.2% | $92K-51.1% | $188K+348,148,048% | ||
| $30.88M-11.5% | $34.88M+636% | $4.74M-0.3% | $4.75M+31.3% | ||
| $19K+58.3% | $12K0.0% | $12K0.0% | $12K-42.9% | ||
| $92.11M+21.0% | $76.12M+140% | $31.74M+26.8% | $25.03M-8.9% | ||
| $10.98M+163% | $4.17M+125% | $1.85M+4.6% | $1.77M-0.5% | ||
| $9.41M+5.5% | $8.91M+65.5% | $5.39M+47.1% | $3.66M+576% | ||
| $8.79M— | $0-100% | $5.38M+421% | $1.03M-27.2% | ||
| $65K-14.5% | $76K+43.4% | $53K-29.3% | $75K— | ||
| $38.49M+93.0% | $19.95M+22.8% | $16.24M+151% | $6.46M+41.8% | ||
| $21.77M-27.0% | $29.81M— | $0-100% | $5.38M+2.3% | ||
| $460K+330% | $107K+386% | $22K-79.4% | $107K+613% | ||
| $0— | $0— | $0— | $0— | ||
| $525K+187% | $183K+144% | $75K-60.1% | $188K— | ||
| $5.24M+186% | $1.83M— | $0— | —— | ||
| $65.96M+27.6% | $51.7M+218% | $16.26M+36.1% | $11.95M+21.5% | ||
| $27K0.0% | $27K+3.8% | $26K+4.0% | $25K-100.0% | ||
| $138.62M+4.8% | $132.29M+10.7% | $119.52M+2.9% | $116.19M+4.0% | ||
| -$112.49M-4.3% | -$107.89M-3.7% | -$104.07M-0.9% | -$103.13M-9.6% | ||
| $26.15M+7.1% | $24.43M+57.8% | $15.48M+18.3% | $13.08M-25.8% | ||
| $92.11M+21.0% | $76.12M+140% | $31.74M+26.8% | $25.03M-8.9% | ||
| $19K+58.3% | $12K0.0% | $12K0.0% | $12K-42.9% | ||
| $310K+77.1% | $175K+90.2% | $92K-51.1% | $188K+80.8% | ||
| $30.88M-11.5% | $34.88M+636% | $4.74M-0.3% | $4.75M+31.3% | ||
| $310K+77.1% | $175K+90.2% | $92K-51.1% | $188K+80.8% | ||
| $19K+58.3% | $12K0.0% | $12K0.0% | $12K-42.9% | ||
| $310K+77.1% | $175K+90.2% | $92K-51.1% | $188K+80.8% | ||
| $19K+58.3% | $12K0.0% | $12K-93.2% | $177K+12.7% | ||
| $9.41M+5.5% | $8.91M+65.5% | $5.39M+47.1% | $3.66M+168% | ||
| $9.41M+5.5% | $8.91M+65.5% | $5.39M+47.1% | $3.66M+168% | ||
| $31.08M+3.6% | $29.99M+450% | $5.46M-17.4% | $6.61M-1.3% | ||
| $138.62M+4.8% | $132.29M+10.7% | $119.52M+2.9% | $116.19M+4.0% | ||
| $27K0.0% | $27K+3.8% | $26K+4.0% | $25K0.0% | ||
| $9.32M+35.7% | $6.87M+89.3% | $3.63M— | —— | ||
| $8.79M— | $0— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Eton Pharmaceuticals, Inc.'s total assets?
- Eton Pharmaceuticals, Inc. (ETON) holds $97.7M in total assets, up 16.3% year over year.
- How much debt does Eton Pharmaceuticals, Inc. have?
- Eton Pharmaceuticals, Inc. carries $31.3M in total debt against $30.6M of shareholders' equity, a debt-to-equity ratio of 1.02.
- How much cash does Eton Pharmaceuticals, Inc. have?
- Eton Pharmaceuticals, Inc. holds $19.7M in cash and equivalents.
- Can Eton Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 1.21 — current assets exceed current liabilities.
- Where does Eton Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
